Atreca, Inc. - stock earnings
BCEL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -36.2 million USD | 80000 USD |
| 2023Q2 | -19.2 million USD | 71000 USD |
| 2023Q1 | -18.8 million USD | 92000 USD |
| 2022Q4 | -20.9 million USD | 20000 USD |
| 2022Q3 | -23.3 million USD | ? USD |
| 2022Q2 | -28.0 million USD | ? USD |
| 2022Q1 | -24.9 million USD | ? USD |
| 2021Q4 | -29.5 million USD | ? USD |
| 2021Q3 | -27.4 million USD | ? USD |
| 2021Q2 | -26.7 million USD | ? USD |
| 2021Q1 | -25.8 million USD | ? USD |
| 2020Q4 | -23.0 million USD | ? USD |
| 2020Q3 | -22.9 million USD | ? USD |
| 2020Q2 | -20.0 million USD | ? USD |
| 2020Q1 | -20.4 million USD | ? USD |
| 2019Q4 | -20.1 million USD | ? USD |
| 2019Q3 | -15.9 million USD | ? USD |
| 2019Q2 | -17.9 million USD | ? USD |
| 2019Q1 | -13.6 million USD | ? USD |
| 2018Q4 | -12.0 million USD | ? USD |
| 2018Q3 | -9.6 million USD | ? USD |
| 2018Q2 | -8.7 million USD | ? USD |
| 2018Q1 | -7.7 million USD | ? USD |
BCEL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -97.8 million USD | ? USD |
| 2022 | -90.5 million USD | 770000 USD |
| 2021 | -109.3 million USD | 851000 USD |
| 2020 | -86.3 million USD | 1.4 million USD |
| 2019 | -67.5 million USD | 2.1 million USD |
| 2018 | -37.9 million USD | ? USD |
| 2017 | -27.5 million USD | ? USD |
BCEL
Price: $0.09
52 week price:
Earnings Per Share: -2.50 USD
P/E Ratio: -0.11
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 154300
Market Capitalization: 3.2 million